Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 2012; Volume 340,Issue 2

Highlighted Papers

  • You have access
    Spleen Tyrosine Kinase Selective Inhibitor and Treatment of Rheumatoid Arthritis
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 227;
  • You have access
    Treating Asthma with Prostaglandin D2 Receptor Antagonists
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 227;
  • You have access
    Mutations of the α1 Glycine Receptor Subunit Regulate Sensitivity to Alcohols
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 227;
  • You have access
    Knockin of Mutated α1 Glycine Receptor Subunits Alters Sensitivity to GABAergic Drugs
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 227;

Behavioral Pharmacology

  • You have access
    Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
    Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  • You have access
    Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
    Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  • You have access
    Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice
    Johan Enquist, Madeline Ferwerda, Laura Milan-Lobo and Jennifer L. Whistler
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 386-392; DOI: https://doi.org/10.1124/jpet.111.187583

Cardiovascular

  • You have access
    Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
    Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906

Cellular and Molecular

  • You have access
    Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
    Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  • You have access
    Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
    Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429
  • You have access
    The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
    Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  • You have access
    Roscovitine Inhibits CaV3.1 (T-Type) Channels by Preferentially Affecting Closed-State Inactivation
    Viktor Yarotskyy and Keith S. Elmslie
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 463-472; DOI: https://doi.org/10.1124/jpet.111.187104

Drug Discovery and Translational Medicine

  • You have access
    Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
    Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  • You have access
    Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
    Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  • You have access
    The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
    Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

Endocrine and Diabetes

  • You have access
    Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
    Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  • You have access
    The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
    Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
    Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  • You have access
    γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
    Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Influence of Influenza A Infection on Capsaicin-Induced Responses in Murine Airways
    Samuel J. Taylor, Tracy S. Mann and Peter J. Henry
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 377-385; DOI: https://doi.org/10.1124/jpet.111.187872
  • You have access
    Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
    Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
    Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  • You have access
    Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
    Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  • You have access
    Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
    Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296

Neuropharmacology

  • You have access
    Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
    Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  • You have access
    Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
    Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
  • You have access
    3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
    Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  • You have access
    The TM2 6′ Position of GABAA Receptors Mediates Alcohol Inhibition
    W. David Johnson, Rebecca J. Howard, James R. Trudell and R. Adron Harris
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 445-456; DOI: https://doi.org/10.1124/jpet.111.188037

Toxicology

  • You have access
    Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
    Taryn T. James, Annayya R. Aroor, Robert W. Lim and Shivendra D. Shukla
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 237-247; DOI: https://doi.org/10.1124/jpet.111.186775
  • You have access
    Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
    Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948

Erratum

  • You have access
    Correction to “The Cytochrome P450 4A/F-20-Hydroxyeicosatetraenoic Acid System: A Regulator of Endothelial Precursor Cells Derived from Human Umbilical Cord Blood”
    Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 490;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 340 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 340, Issue 2
1 Feb 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Toxicology
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics